Novel Drug Delivery System

Interact & exchange stock tips & market info »
Related News »
is developing novel proprietary drug delivery products to treat cancer and other serious life threatening diseases. NanoSmart's patented platform drug delivery system utilizes human autoimmune antibodies that target many different types of ...
May 24, 2012 at 12:16 | Source: Marketwatch
The unique delivery system and bioabsorbable drug carrier, coupled with a proven drug compound, make for a truly novel drug-eluting stent platform. We look forward to sharing the robust 30-day clinical outcomes from the DIRECT study,” said Mark Webster ...
May 15, 2012 at 07:11 | Source: Business Wire
The unique delivery system and bioabsorbable drug carrier, coupled with a proven drug compound, make for a truly novel drug-eluting stent platform. We look forward to sharing the robust 30-day clinical outcomes from the DIRECT study," said Mark ...
May 15, 2012 at 12:05 | Source: News-Medical.Net
REDWOOD CITY, CA — ApniCure, a medical device company focused on developing and commercializing novel ... U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market its Winx™ Sleep Therapy System in the ...
May 18, 2012 at 11:54 | Source: msnbc.com
BOTHELL, WA--(Marketwire -05/10/12)- Marina Biotech, Inc. (MRNA.PK), a leading nucleic acid-based drug ... system. Part of this endeavor involved determining whether the DiLA2 and SMARTICLES delivery technologies could be integrated, and novel ...
May 27, 2012 at 01:56 | Source: Yahoo Finance
The authors explained that the development of novel antibiotics that can be used effective ... capped with polyethylene glycol (PEG), which is commonly used for drug delivery due to its nontoxic properties and because it can help to transport ...
May 7, 2012 at 06:59 | Source: Medical News Today
IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IntelGenx uses its unique multiple layer delivery system to provide zero-order release ...
May 15, 2012 at 10:10 | Source: msnbc.com
APS meeting highlights include the following: Current models of US health care delivery offer both obstacles ... developed target both the peripheral nervous system and the CNS. NGX-1998, a novel liquid formulation of high concentration ...
May 23, 2012 at 17:17 | Source: Marketwatch
REDWOOD CITY, CA -- (Marketwire) -- 05/21/12 -- ApniCure, Inc. a medical device company focused on developing and commercializing novel home-use devices ... from the U.S. Food and Drug Administration to market the Winx system," said Steve Carlson ...
May 21, 2012 at 20:26 | Source: IT Business Net (press release) (subscription)